Auxilium May Have Peyronie's Treatment , CEO Says

Thu, 06/07/2012 - 20:21 EDT - Bloomberg - Video News

Auxilium May Have Peyronie's Treatment , CEO Says

June 7 (Bloomberg) -- Adrian Adams, chief executive officer of Auxilium Pharmaceuticals Inc., talks about the company's Xiaflex treatment for Peyronie's disease. He speaks with Pimm Fox on Bloomberg Television's "Taking Stock." (Source: Bloomberg)
From:
Bloomberg
Views:
11

0
ratings
Time:
03:20
More in
Entertainment

Original article
Login or register to post comments

Related

Anido Says Auxilium's Xiaflex May Be `Blockbuster' Drug: Video
JPMorgan Loss Not Enough to Avoid Stock
Resource Stocks `Amazingly Cheap,' Adrian Day Says
Bloomberg's Harper Reviews Dodge Charger SRT8
Auxilium Pharmaceuticals Management Discusses Q4 2012 Results - Earnings Call Transcript
Auxilium Pharmaceuticals (AUXL) Q4 2012 Earnings Call February 26, 2013 10:00 am ET Executives Adrian Adams - Chief Executive Officer, President and Director William Q. Sargent - Vice President of Investor Relations and Corporate Communications James E. Fickenscher - Chief Financial Officer and Principal Accounting Officer Analysts Eric Schmidt - Cowen and Company, LLC, Research Division
Auxilium Pharmaceuticals Management Discusses Q3 2012 Results - Earnings Call Transcript
Auxilium Pharmaceuticals (AUXL) Q3 2012 Earnings Call November 07, 2012 10:00 am ET Executives Adrian Adams - Chief Executive Officer, President and Director William Q. Sargent - Vice President of Investor Relations and Corporate Communications James E. Fickenscher - Chief Financial Officer and Principal Accounting Officer Analysts Eric Schmidt - Cowen and Company, LLC, Research Division
US Stock Market, European Debt Crisis, Investing
Zee Telefilms CEO on Company Outlook
Licamele on Russian Stock Picks
Abraham Says ComScore `Purely' a Measurement Company

Secondary menu